Medicis Pharmaceutical Corp.

Mark A. Prygocki has served as Chief Operating Officer since April 2008, and as Executive Vice President since January 2001. Mr. Prygocki joined Medicis in 1991 and was appointed to the position of Chief Financial Officer, Treasurer and Corporate Secretary in May 1995. From October 1991 to May 1995, he served as Controller. From July 1990 through October 1991, he was employed by Citigroup, an investment banking firm, in the regulatory reporting division. Prior to that, Mr. Prygocki spent several years in the audit department of Ernst & Young, LLP. Mr. Prygocki is a member of the Financial Executive Institute, and is certified by the Arizona State Board of Accountancy and the New York Society of CPAs. Mr. Prygocki serves on the Boards of Whispering Hope Ranch Foundation and Visions of Hope, Inc., non-profit organizations that assist children with special needs.

Mitchell S. Wortzman, Ph.D. has served as Chief Scientific Officer and as an Executive Vice President of the Company since July 2003. Prior to that, he served as Executive Vice President, Research and Development of the Company from January 2001 to July 2003 and as Senior Vice President, Research and Development of the Company from August 1997 to January 2001. From 1980 to 1997, Dr. Wortzman was employed at Neutrogena Corporation, most recently serving as President of the Dermatologics Division since 1989.

Richard D. Peterson has served as Executive Vice President, Chief Financial Officer and Treasurer since April 2008. Mr. Peterson also serves as Chief Accounting Officer. Mr. Peterson has held various finance related positions with Medicis since 1995. From February 2007 to April 2008, Mr. Peterson served as Senior Vice President of Finance. From August 2002 to February 2007, he served as Vice President of Finance. Prior to joining Medicis, Mr. Peterson was employed by PricewaterhouseCoopers as a member of the audit department. Mr. Peterson is a member of the Financial Executives Institute and serves on the board of the Phoenix Zoo, a non-profit organization.

Jason Hanson has served as Executive Vice-President, General Counsel, and Corporate Secretary since July, 2006. From April 2004 to July 2006, Mr. Hanson served as General Counsel for GE Healthcare Technologies, a global business specializing in medical imaging, information technology and other durable medical equipment and services, where he was responsible for the global legal affairs of GE Healthcare Technologies and a member of the company’s senior management team. From 2001 to 2004, Jason served as General Counsel for the Americas, GE Medical Systems. Mr. Hanson joined GE in 1999 serving as Senior Counsel for Litigation and Compliance for GE Medical Systems. Mr. Hanson began his legal career with Arnold & Porter in Washington, D.C. concentrating his practice in litigation, intellectual property and commercial disputes. From 1997 to 1999, Jason served with the United States Department of Justice, Antitrust Division in Washington D.C. as a prosecutor and trial attorney in what is now known as the National Criminal Enforcement Section. Mr. Hanson earned his law degree at Duke University, where he was an editor of the law review, and earned his undergraduate degree in Economics from Cornell University.

Joseph P. Cooper has served as Executive Vice President, Corporate and Product Development since July 2006. From January 2001 to July 2006, Mr. Cooper served as Executive Vice President, Corporate Development. From February 1996 to January 2001, Mr. Cooper served as Senior Vice President, Manufacturing and Distribution. Prior to that, he held management positions with Schein Pharmaceuticals, Inc. and G.D. Searle. Mr. Cooper serves on the Board of Directors for the Southwest Autism Research and Resource Center, and serves as past Chairman of the Board of Directors for Communities in Schools of Arizona.

Vincent Ippolito has served as Executive Vice President, Sales and Marketing since April 2008. Mr. Ippolito joined Medicis in 2003 and most recently served as Senior Vice President of North American Sales since January 2006. From January 2003 to January 2006, he served as General Manager of Dermatology products, responsible for the marketing and sales functions. During his tenure at Medicis, he has helped launch more than ten new products, including LOPROX® Shampoo, VANOS®, RESTYLANE®, PERLANE®, SOLODYN®, and ZIANA®. Prior to joining Medicis, Mr. Ippolito was employed by Novartis AG from 1986 to 2003, where he served in a variety of sales and marketing roles, including General Manager, Marketing Group Brand Leader for Dermatology and Bone Products, and Vice President of Sales in the Respiratory and Dermatology Division.

Mr. Knight has been a Director of the Company since June 2000. Mr. Knight has been President of Generation Investment Management US, a London-based asset management company, since August 2004. From 2001-2003, he was a Managing Director of MetWest Financial. Prior to that, Mr. Knight s business experience included serving as general counsel of Medicis Pharmaceutical and a practicing attorney. Mr. Knight s experience also includes serving as chief of staff to Al Gore when Mr. Gore was a member of the U.S. House of Representatives and later the U.S. Senate and holding senior positions with four presidential campaigns, including serving as campaign manager for the successful 1996 re-election of President Clinton. Mr. Knight currently serves as a director of Medicis Pharmaceutical Corp. and Par Pharmaceuticals. He is also a director of Schroders mutual fund and hedge fund family, a member of the Cornell University College of Arts and Sciences Advisory Council, and the Johnson Schools Center for Sustainable Global Enterprise.

Lottie H. Shackelford has been a director since July 1993. Ms. Shackelford has been Executive Vice President of Global USA, Inc., a government relations firm, since April 1994, and has been Vice Chair of the Democratic National Committee since February 1989. Ms. Shackelford was Executive Vice President of U.S. Strategies, Inc., a government relations firm, from April 1993 to April 1994. She was also Co-Director of Intergovernmental Affairs for the Clinton/Gore presidential transition team between November 1992 and March 1993; Deputy Campaign Manager of Clinton for President from February 1992 to November 1992; and Executive Director, Arkansas Regional Minority Purchasing Council, from February 1982 to January 1992. In addition, Ms. Shackelford has served in various local government positions, including Mayor of Little Rock, Arkansas. She also is a former director of Philander Smith College, the Chapman Funds in Baltimore, Maryland, and the Overseas Private Investment Corporation.

Michael A. Pietrangelo has been a director since October 1990. Admitted to the bar in New York, Tennessee and the District of Columbia, he was an attorney with the Federal Trade Commission and later for Pfizer, Inc., from 1967 to 1972. Mr. Pietrangelo then joined Schering-Plough Corporation in Memphis, Tennessee in 1972, first as Legal Director and as Associate General Counsel. During that time, he was also appointed Visiting Professor of Law by the University of Tennessee and University of Mississippi School of Pharmacy. In 1980, Mr. Pietrangelo left corporate law and focused on consumer products management, serving in a variety of executive positions at Schering-Plough Corporation prior to being named President of the Personal Care Products Group in 1985. In 1989, he was asked to join Western Publishing Group as President and Chief Operating Officer. From 1990 to 1994, Mr. Pietrangelo was the President and Chief Executive Officer of CLEO, Inc., a Memphis-based subsidiary of Gibson Greetings, Inc., a manufacturer of specialized paper products. In 1994, he accepted a position as President of Johnson Products Company, a subsidiary of IVAX Corporation. He served in that capacity until February 1998, when he returned to the practice of law with Pietrangelo Cook PLC, based in Memphis, Tennessee.

Spencer Davidson , age 66, has been our director since January 1999. Since 1994, Mr. Davidson has served as President, Chief Executive Officer and director, and since April of 2007 has served as Chairman, of General American Investors Company, Inc., a closed-end investment company listed on the New York Stock Exchange. His background also includes a distinguished career on Wall Street with positions held at Brown Brothers Harriman; Beck, Mack & Oliver, investment counselors, where he served as General Partner; and Odyssey Partners, a private investment firm, where he served as Fund Manager. Additionally, Mr. Davidson currently serves as the General Partner of The Hudson Partnership, a private investment partnership, and serves as Trustee for both the Innisfree Foundation, Inc. of Millbrook, New York, and the Neurosciences Research Foundation, Inc. of San Diego, California. A graduate of City College and Columbia University, Mr. Davidson holds an M.B.A., a C.F.A. and a C.I.C.